Page last updated: 2024-09-04

olmesartan and Cognition Disorders

olmesartan has been researched along with Cognition Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beloborodov, VA; Borisova, VM; Golub, IY; Kur'yanov, AA; Sorokina, LV	1
Kano, M; Kurinami, H; Morishita, R; Niisato, K; Ogihara, T; Rakugi, H; Sato, N; Shinohara, M; Takeda, S; Takeuchi, D	1
Fujita, T; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K	1

Trials

1 trial(s) available for olmesartan and Cognition Disorders

Article	Year
[COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY]. Vestnik khirurgii imeni I. I. Grekova, 2015, Volume: 174, Issue:4 Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Hyperparathyroidism; Imidazoles; Inosine Diphosphate; Niacinamide; Postoperative Complications; Prognosis; Prospective Studies; Succinates; Tetrazoles; Thyroidectomy	2015

Article

Year

[COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY].

Vestnik khirurgii imeni I. I. Grekova, 2015, Volume: 174, Issue:4

Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin Mononucleotide; Follow-Up Studies; Humans; Hyperparathyroidism; Imidazoles; Inosine Diphosphate; Niacinamide; Postoperative Complications; Prognosis; Prospective Studies; Succinates; Tetrazoles; Thyroidectomy

2015

Other Studies

2 other study(ies) available for olmesartan and Cognition Disorders

Article	Year
Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Cerebrovascular Circulation; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Imidazoles; Male; Maze Learning; Mice; Mice, Transgenic; Microcirculation; Neuronal Plasticity; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Renin-Angiotensin System; Tetrazoles	2009
Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan. Neuropharmacology, 2007, Volume: 53, Issue:8 Topics: Age Factors; Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Blood Pressure; Body Weight; Brain; Cholesterol; Cognition Disorders; Gene Expression Regulation; Imidazoles; Male; Mice; Mice, Inbred C57BL; Sodium Chloride, Dietary; Superoxides; Tetrazoles; Ubiquitin-Conjugating Enzymes	2007

Article

Year

Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.

Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6

Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II Type 1 Receptor Blockers; Animals; Cerebrovascular Circulation; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Imidazoles; Male; Maze Learning; Mice; Mice, Transgenic; Microcirculation; Neuronal Plasticity; Oxidative Stress; Peptide Fragments; Reactive Oxygen Species; Renin-Angiotensin System; Tetrazoles

2009

Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan.

Neuropharmacology, 2007, Volume: 53, Issue:8

Topics: Age Factors; Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Blood Pressure; Body Weight; Brain; Cholesterol; Cognition Disorders; Gene Expression Regulation; Imidazoles; Male; Mice; Mice, Inbred C57BL; Sodium Chloride, Dietary; Superoxides; Tetrazoles; Ubiquitin-Conjugating Enzymes

2007